IMA vs TT · rev $9.2M vs P/E 36, rev $21.32B
ImageneBio, Inc. (IMA) versus Trane Technologies plc (TT) — a side-by-side from cached financials, not a winner call.
ImageneBio, Inc. (IMA) is a biotechnology company listed on NASDAQ.
Trane Technologies plc (TT) is a building products & equipment company listed on NYSE.
Latest reported IMA revenue for 2023-12-31 was $9.2M. Net income was -$68.2M. Revenue was down 41.3% from 2022-12-31 to 2023-12-31. IMA currently screens at market cap $64.7M.
Latest reported TT revenue for 2025-12-31 was $21.32B. Net income was $2.92B. Revenue was up 7.5% from 2024-12-31 to 2025-12-31. TT currently screens at market cap $104.45B and trailing P/E 36.2.
IMA currently screens at market cap $64.7M. TT currently screens at market cap $104.45B and trailing P/E 36.2.
Not investment advice. Open the IMA and TT stock pages for the full models.
Not investment advice.